MercoPress, en Español
Get our news on your inbox! Suscribe x
Montevideo, May 21st 2022 - 21:42 UTC
A pill to treat COVID-19 patients can now be distributed throughout Paraguay's conventional pharmaceutical network after two local laboratories were granted a registration license to manufacture Molnupiravir, the pill developed by Merck.
Get our news on your inbox!